TVTX

Travere Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$30.44

Market Cap

$2.81B

Beta

0.88

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+110.46%

EPS Growth (YoY)+85.37%

Revenue CAGR 3Y+38.03%

P/E Ratio0.0

PEG Ratio—

FCF Yield+0.93%

Debt / Equity2.96

Interest Coverage-5.8x

No credit card required

Already have an account? Sign in to view the full analysis for TVTX.